Effect of SSRIs on Mood Disorders

My Work

1

The course provided a thorough understanding of the basic mechanisms of neurotransmission, including the different types of neurotransmitters and their functions. The course also explained how psychotropic medications target specific neurotransmitter systems to treat various mental health conditions. For example, selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for depression and anxiety disorders because they increase the availability of serotonin in the brain, a neurotransmitter associated with mood regulation (Hjorth et al., 2021).

The course covered major categories of psychotropic drugs, including antidepressants, antipsychotics, anxiolytics, and mood stabilizers. It explained the rationale for using these medications, their mechanisms of action, and common side effects associated with their use. For example, antipsychotics are used to treat schizophrenia and bipolar disorder because they block dopamine receptors, a neurotransmitter that is overactive in these conditions. At the same time, these drugs can have negative side effects.

The course additionally covered the use of complementary and alternative medications in the treatment of mental health conditions, including herbal remedies and dietary supplements. The course emphasized the importance of evidence-based practice and the need to consider cultural and genetic factors as well as patient values when making treatment decisions. For example, some cultural groups may prefer traditional herbal remedies over prescription medications for the treatment of mental health conditions.

The course also provided an overview of common clinical assessment tools used in the diagnosis and treatment of psychiatric disorders, including the Diagnostic and Statistical Manual of Mental Disorders (DSM) and various rating scales. It emphasized the importance of using these tools in clinical settings to improve diagnostic accuracy and treatment planning.

The course provided a framework for making treatment decisions based on factors such as safety concerns, current mental health, medical concerns, age, gender, cultural factors, genetic factors, ethical concerns, patient values, and prescriptive authority. It emphasized the need to consider these factors when making treatment decisions and provided examples of how they may impact treatment decisions in different clinical scenarios.

It also emphasized the importance of utilizing research to guide treatment decisions and the need to provide education to clients and their families about diagnostic and psychopharmacology options. To this end, it offered examples of how to communicate effectively with clients and their families about treatment options and the risks and benefits associated with different medications.

Finally, the course discussed various ethical and legal considerations related to the pharmacological treatment of mental health patients, including informed consent, confidentiality, and prescribing authority. It showed the need to balance patient autonomy with the duty to protect patient safety and provided examples of how to navigate ethical and legal dilemmas in clinical practice.

2

The material learned in this course will be highly applicable to professional practice for healthcare providers involved in the treatment of patients with acute and chronic mental health conditions. Through understanding the fundamentals of neurotransmission and major categories of psychotropic drugs, I will be able to make informed decisions about medication management for their patients. I will also be able to utilize clinical assessment tools to improve diagnostic accuracy and treatment planning.